financetom
Business
financetom
/
Business
/
Market Chatter: Nutrien Plans Exit From Argentina, Chile
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Nutrien Plans Exit From Argentina, Chile
Apr 15, 2024 3:28 AM

06:10 AM EDT, 04/15/2024 (MT Newswires) -- Nutrien Ltd. ( NTR ) , the world's largest maker of fertilizers, said it is seeking to sell its retail operations in Argentina, Chile and Uruguay in order to focus on Brazil and other global markets, Bloomberg reported Friday

The Canadian company is prioritizing key markets in a bid to boost returns for investors, a spokesperson said in an emailed statement to Bloomberg.

According to the report, "Nutrien ( NTR ), which has been in South America for more than a quarter of a century, is working to recover after sharply missing profit expectations in the last three months of 2023 amid plunging fertilizer prices that hurt retail results.

"The company said in its annual report that Argentina's currency controls meant it lost money when it transferred currency out of the country because it had to use a more expensive exchange rate. New President Javier Milei has promised to scrap the controls as he seeks to deregulate the economy.

"Its exit from the Argentine retail business comes as the country seeks to cheapen the herbicide and fertilizer market for farmers by reducing import taxes on both inputs.

"Other companies have also abandoned Argentina's tough business environment in recent years, including HSBC Holdings PLC and Walmart Inc. Bayer AG ditched its Argentine soy seed business in 2021.

"Nutrien ( NTR ) didn't say what it's planning to do with its 50% stake in Profertil SA, a urea and ammonia manufacturing venture it has with Argentina state-run oil company YPF SA. YPF, under new management appointed by Milei, is looking to divest assets to focus on shale drilling."

Nutrien ( NTR ) on Friday said it would continue to support all customers and partners through its divestiture process.

(Market Chatter news is derived from conversations with market professionals globally, and/or from other media sources. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Traders seek refuge in Aussie consumer staples as US tariffs spark market fall
Traders seek refuge in Aussie consumer staples as US tariffs spark market fall
Apr 3, 2025
By Rajasik Mukherjee (Reuters) - Shares of Australia's consumer staple companies rose on Thursday, driven by grocers Coles and Woolworths, as investors moved to safer bets after U.S. President Donald Trump's reciprocal tariffs sparked global market turmoil. Shares of the sector ended 1.3% higher while the broader Australian market fell 0.9% to its lowest since March 14. Coles rose 2.1%...
Trump's Tariffs Announcement 'Worse Than the Worst Case Scenario,' Wedbush Says
Trump's Tariffs Announcement 'Worse Than the Worst Case Scenario,' Wedbush Says
Apr 3, 2025
04:35 AM EDT, 04/03/2025 (MT Newswires) -- The slate of tariffs from the Trump administration is worse than the worst case scenario feared by analysts, according to Wedbush Securities. In a note emailed to clients on Wednesday, Wedbush analysts, led by Daniel Ives, said tech stocks will be under major pressure following the announcement. On Wednesday, the Trump administration unveiled...
Mesoblast Files Meeting Request With FDA for Ischemic Heart Failure Treatment Candidate
Mesoblast Files Meeting Request With FDA for Ischemic Heart Failure Treatment Candidate
Apr 3, 2025
04:23 AM EDT, 04/03/2025 (MT Newswires) -- Mesoblast (MESO) said late Wednesday it expets to have a type B meeting with the US Food and Drug Administration during the current quarter to discuss the accelerated approval pathway for ischemic heart failure treatment candidate, Revascor. The main goals of the meeting are to get FDA feedback on relevant chemistry, manufacturing &...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved